Page last updated: 2024-11-04

carbamylhydrazine and Malignant Melanoma

carbamylhydrazine has been researched along with Malignant Melanoma in 1 studies

carbamylhydrazine: RN given refers to parent cpd

Research Excerpts

ExcerptRelevanceReference
"Our previous studies have shown that 4-S-cysteaminylphenol (4-S-CAP) causes a significant inhibition of in vivo melanoma growth and a marked depigmentation of black skin and hair follicles."7.68Mechanism of growth inhibition of melanoma cells by 4-S-cysteaminylphenol and its analogues. ( Fujita, K; Inoue, S; Ito, S; Jimbow, K; Wakamatsu, K, 1990)
"Our previous studies have shown that 4-S-cysteaminylphenol (4-S-CAP) causes a significant inhibition of in vivo melanoma growth and a marked depigmentation of black skin and hair follicles."3.68Mechanism of growth inhibition of melanoma cells by 4-S-cysteaminylphenol and its analogues. ( Fujita, K; Inoue, S; Ito, S; Jimbow, K; Wakamatsu, K, 1990)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Inoue, S1
Ito, S1
Wakamatsu, K1
Jimbow, K1
Fujita, K1

Other Studies

1 other study available for carbamylhydrazine and Malignant Melanoma

ArticleYear
Mechanism of growth inhibition of melanoma cells by 4-S-cysteaminylphenol and its analogues.
    Biochemical pharmacology, 1990, Mar-15, Volume: 39, Issue:6

    Topics: Antineoplastic Agents; Cell Division; Chromatography, High Pressure Liquid; Cysteamine; Humans; Mela

1990